Eight NHS Genomic Networks of Excellence launched in England

In January 2024, eight NHS Genomic Networks of Excellence were launched within the NHS Genomic Medicine Service (GMS). NHS England is funding these innovative networks to develop the evidence and model of adoption for cutting-edge genomic advances and technology applications. The Networks of Excellence are designed to be partnerships between the NHS, academia, the third sector, and industry to leverage expertise and resources from the broader genomics ecosystem and inform commissioning decisions.

The following NHS Genomic Networks of Excellence have been established:

• Prenatal genomic medicine;
• Circulating tumor biomarker testing (ctDNA);
• Haemato-oncology network;
• Rare and inherited disease network;
• Severe presentation of infectious disease;
• Improving the identification and outcomes for individuals with inherited and acquired cardiovascular disease;
• Pharmacogenomic and medicines optimization;
• Genomics artificial intelligence (AI).

See the full details here.

This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.